Drug Shortage Report for TARO-ZOLEDRONIC ACID CONCENTRATE
Report ID | 170 |
Drug Identification Number | 02415186 |
Brand name | TARO-ZOLEDRONIC ACID CONCENTRATE |
Common or Proper name | Zoledronic Acid for injection |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | ZOLEDRONIC ACID |
Strength(s) | 4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5ml |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2016-01-01 |
Actual start date | 2016-01-01 |
Estimated end date | 2018-02-26 |
Actual end date | 2018-02-08 |
Shortage status | Resolved |
Updated date | 2018-02-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-10 | English | Compare |
v2 | 2017-03-10 | French | Compare |
v3 | 2017-05-13 | English | Compare |
v4 | 2017-05-13 | French | Compare |
v5 | 2017-07-07 | English | Compare |
v6 | 2017-07-07 | French | Compare |
v7 | 2017-08-02 | English | Compare |
v8 | 2017-08-02 | French | Compare |
v9 | 2017-10-02 | English | Compare |
v10 | 2017-10-02 | French | Compare |
v11 | 2017-11-03 | English | Compare |
v12 | 2017-11-03 | French | Compare |
v13 | 2017-12-04 | English | Compare |
v14 | 2017-12-04 | French | Compare |
v15 | 2017-12-25 | English | Compare |
v16 | 2017-12-25 | French | Compare |
v17 | 2018-01-18 | English | Compare |
v18 | 2018-01-18 | French | Compare |
v19 | 2018-02-02 | English | Compare |
v20 | 2018-02-02 | French | Compare |